<DOC>
	<DOC>NCT01260636</DOC>
	<brief_summary>To compare two gadolinium contrast agents in terms of global paired diagnostic preference (primary endpoint) for the assessment of contrast-enhanced MR Angiography of the carotid, renal/abdominal and peripheral arteries</brief_summary>
	<brief_title>Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<criteria>18 yrs of age or older referred for enhanced MRA of carotid, renal/abdominal or peripheral arteries Able to provide written informed consent and comply with protocol requirements Highly suspected of or with known disease of the carotid, renal/abdominal or peripheral vasculature using specific criteria listed in the protocol pregnant or lactating females Known allergy to one or more of the ingredients in the products under investigation Significant congestive heart failure ( Class IV) Moderate to severe chronic kidney disease Therapeutic intervention of any kind for vascular disease in the territory of interest between the two contrast procedures Vascular stents in vessels of interest Received another contrast agent in the 24 hrs preceding or proceeding each exam Previously entered into the study Contraindications to MRI Severe Claustrophobia Undergone DSA between the two exams</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2012</verification_date>
</DOC>